KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Operating Expenses (2016 - 2025)

Chemed (CHE) has 17 years of Operating Expenses data on record, last reported at $538.7 million in Q4 2025.

  • For Q4 2025, Operating Expenses rose 2.39% year-over-year to $538.7 million; the TTM value through Dec 2025 reached $2.2 billion, up 6.15%, while the annual FY2025 figure was $2.2 billion, 6.15% up from the prior year.
  • Operating Expenses reached $538.7 million in Q4 2025 per CHE's latest filing, down from $550.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $552.2 million in Q1 2025 and bottomed at $439.4 million in Q2 2022.
  • Average Operating Expenses over 5 years is $488.4 million, with a median of $481.0 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: increased 13.57% in 2021, then dropped 4.6% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $442.9 million in 2021, then rose by 5.05% to $465.3 million in 2022, then increased by 1.98% to $474.5 million in 2023, then grew by 10.87% to $526.1 million in 2024, then increased by 2.39% to $538.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $538.7 million in Q4 2025, $550.2 million in Q3 2025, and $550.7 million in Q2 2025.